|
2.
|
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis. MedStar authors:
Year: 2024
Citation: - The Lancet Diabetes & Endocrinology. 12(7):447-461, 2024 Jul.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
- Journal Article
- Meta-Analysis
- Systematic Review
All authors: - Usman MS, Bhatt DL, Hameed I, Anker SD, Cheng AYY, Hernandez AF, Jones WS, Khan MS, Petrie MC, Udell JA, Friede T, Butler J
|